Itochu invests in United Immunity via private placement
Itochu invested in United Immunity via a private placement, taking a minority equity stake. Deal supports United Immunity’s Myeloid Targeting Platform nanoparticle technology, including an in vivo CAR-macrophage cancer therapy program. United Immunity cited JPY 2.2 billion raised from the private-sector capital increas